Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Strive, Inc. (Nasdaq: ASST) SEC filings page on Stock Titan provides direct access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. Strive uses these filings to report on its Bitcoin treasury activities, capital structure decisions, preferred equity terms, and material corporate events, giving investors a primary source of regulatory information about ASST.
As an asset management Bitcoin treasury company, Strive’s filings often focus on digital asset holdings and financing. Form 8-K current reports describe large Bitcoin purchases funded through PIPE proceeds, warrant exercises, and the issuance of its Variable Rate Series A Perpetual Preferred Stock (SATA). These filings disclose aggregate Bitcoin holdings, acquisition costs, and the company’s view of its position among corporate Bitcoin holders.
Strive’s SEC documents also explain the detailed terms of the SATA Stock. Through 8-Ks and related exhibits, the company outlines the variable dividend structure, liquidation preference, seniority relative to common stock, compounded dividends on unpaid amounts, redemption features, and investor protections that apply if certain events occur. Additional filings report monthly dividend declarations on SATA and discuss the expected return-of-capital tax treatment of these distributions, including the company’s statement that it does not have accumulated earnings and profits.
Investors can also use Strive’s filings to review quarterly and transactional disclosures. Form 8-Ks reference quarterly financial results, the consummation of a reverse acquisition of Asset Entities Inc., and the registration of large blocks of Class A common stock for resale. Other filings describe amendments to Strive’s articles of incorporation and bylaws, changes in board composition, and the registration statements related to its proposed all-stock merger with Semler Scientific, Inc.
On Stock Titan, these filings are supplemented with AI-powered summaries that highlight key points from lengthy documents such as registration statements, 8-Ks, and prospectus supplements. Users can quickly see what each filing covers—whether it is a Bitcoin purchase disclosure, a SATA dividend update, or a merger-related communication—while retaining the ability to read the full text for deeper analysis. This makes the ASST filings page a practical starting point for understanding Strive’s regulatory history, capital markets activity, and Bitcoin-focused strategy.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). Strive has filed a Form S-4 to register the Class A common stock to be issued in the transaction, which will include an information statement, proxy statement, and prospectus.
Semler Scientific stockholders will receive a definitive proxy/prospectus to vote on the deal. The communication includes forward‑looking statement cautions, explains how to access SEC filings, notes potential proxy “participants,” and clarifies it is not an offer to sell or solicit securities.
Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in connection with the transaction. A combined information statement/proxy statement/prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication includes forward-looking statement cautions and directs investors to the SEC’s website and company investor pages for the Registration Statement and related materials when available.
Strive, Inc. released a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR), which was reposted on X.com by board member Pierre Rochard on November 10, 2025.
Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction. The S-4 includes an information statement/proxy statement/prospectus, and a definitive version will be sent to Semler stockholders to seek their approval.
The notice includes forward‑looking statement cautions, directs investors to the SEC and company websites for documents, identifies potential proxy solicitation participants, and states it is not an offer or solicitation.
Strive, Inc. filed a Rule 425 communication related to its proposed business combination with Semler Scientific (SMLR). The notice includes a forward‑looking statements caution and outlines that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction. The S‑4 will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
Semler Scientific stockholders will receive a definitive Information Statement/Proxy Statement/Prospectus to consider and vote on the proposed transaction. Investors are urged to read these materials when available, as they will contain important details about the companies and the deal. The communication emphasizes it is not an offer or solicitation to sell securities. Documents will be available free of charge on the SEC’s website and the companies’ investor relations pages.
Semler Scientific (SMLR) and Strive, Inc. announced a transaction-related communication under Rule 425, tied to their proposed business combination. The notice emphasizes forward-looking statement cautions and outlines the path to closing.
Strive has filed a Form S-4 to register the Class A common stock to be issued in the deal, which will include an information statement/proxy statement/prospectus. A definitive version will be sent to Semler Scientific stockholders to seek their approval. Investors are directed to review the S-4 and related materials when available on the SEC’s website and each company’s investor relations pages. The communication also clarifies this is not an offer to sell or solicit the purchase of securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. The notice emphasizes forward‑looking statement cautions and directs investors to official SEC materials.
Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction. A combined information statement, proxy statement, and prospectus will be sent to Semler stockholders to seek approval. The companies note that this is not an offer or solicitation and urge investors to read the Registration Statement and related documents when available.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward‑looking statement cautions and states it is not an offer or solicitation. Related documents, when available, can be obtained free of charge from the SEC’s website and each company’s investor relations pages.
Semler Scientific and Strive announced a proposed business combination and related investor communications filed under Rule 425. Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive. Semler Scientific stockholders will receive definitive proxy materials to vote on the deal.
The communication emphasizes forward-looking statement cautions and directs investors to SEC filings for details, including Strive’s S-4 filings dated August 6, 2025 and October 10, 2025, and each company’s periodic reports. It clarifies this is not an offer to sell or buy securities; any offer will be made only by a prospectus meeting Section 10 of the Securities Act or an applicable exemption.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. The message notes that Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction and that an Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval.
The communication includes extensive forward-looking statement cautions and directs investors to the SEC’s website for free copies of the S-4 and related documents. It also states that directors, officers and employees of both companies may be participants in the proxy solicitation and concludes with a standard “no offer or solicitation” disclaimer.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement, proxy statement and prospectus.
A definitive proxy will be sent to Semler Scientific stockholders to seek approval. The notice includes forward-looking statement cautions and clarifies it is not an offer or solicitation. Investors can access related SEC filings for full details.